SAMHSA and FDA Join to Educate the Public on the Safe Use of Methadone
The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) and the U.S. Food and Drug Administration (FDA) today launched an initiative to help ensure the safe use of methadone. A prescription drug best known as a treatment for addiction and dependence on heroin and other narcotic pain medicines, methadone is also prescribed to treat moderate-to-severe chronic pain patients. The campaign responds to concerns about an escalating number of poisoning deaths linked to the improper use of this medication.
The public outreach effort, Follow Directions: How to Use Methadone Safely, is designed to inform consumers, health care professionals and treatment clinics about the safe use and misuse of the drug for both pain relief and drug addiction treatment.
Methadone is a synthetic opioid that has been used for decades to reduce drug withdrawal symptoms. Recently, it has been increasingly prescribed as a pain reliever for patients whose moderate-to-severe chronic pain does not respond to non-narcotic pain medications.
Continue Reading
|
|
|
|
|
|
For more information, contact SAMHSA’s Health Information Network or visit SAMHSA's Web site: |
|
|
|
|
|
1-877-SAMHSA-7
(English and Spanish/inglés y español) |
|
|
|
|
|
|
|
|
|
|
|
|
|